# Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder

> **NCT04768816** · PHASE1 · UNKNOWN · sponsor: **Guangdong Women and Children Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Safety Issues;Effect of Drugs

## Interventions

- **DRUG:** 0.9% Sodium Chloride
- **BIOLOGICAL:** Autologous Umbilical Cord Blood

## Key facts

- **NCT ID:** NCT04768816
- **Lead sponsor:** Guangdong Women and Children Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768816, "Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04768816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*